International Conference on Cannabis Research confirms venue

The International Cannabinoid Research Society (the oldest scientific society dedicated to the research in the cannabis plant) has announced that the International Symposium on the Cannabinoids in 2021 will take place at the International Convention Center (ICC) in Jerusalem, in cooperation with the Jerusalem Conventions & Visitors Bureau (JCVB), which operates under the Jerusalem Development Authority (JDA). The event will be hosted by the Hebrew University’s Multidisciplinary Center on Cannabinoid Research, which is the leading centre in Israel for conducting and coordinating research on cannabinoids, endocannabinoids and medical Cannabis. The International Symposium will mark professor Mechoulam’s 90th birthday in his home town of Jerusalem. “As the largest and leading conference centre in Israel, the Jerusalem ICC looks forward to hosting this important conference aimed at bringing international researchers together to improve human health and well-being,” said Mira Altman, CEO of the International Convention Center (ICC) in Jerusalem. “Bringing this global symposium to Jerusalem emphasizes the ongoing collaboration between multiple institutions including the JCVB, ICC, and MCCR. This partnership was only possible with the shared vision in highlighting the city’s potential as a leading scientific conference destination. Jerusalem offers an ideal setting to host over 400 global researchers, to learn and promote the exchange of scientific information and gain new perspectives about Cannabis,” said Ilanit Melchior, director of tourism in Jerusalem. Professor Cecilia Hillard, executive director of the ICRS, said: “The board of directors of the International Cannabinoid Research Society is very pleased that our 31st annual meeting will be held in Jerusalem in 2021. Jerusalem holds a special place in the history of the science of cannabis and the endocannabinoids. Professor Raphael Mechoulam of Hebrew University was the first to publish the structure of the active principal of cannabis, THC and was also the first to identify an endogenous cannabinoid, anandamide.”